Bamlanivimab, CAS 2423943-37-5

Product Description: Bamlanivimab (Anti-Human SARS-CoV-2) is the first COVID-19 monoclonal antibody (mAb) to be granted Emergency Use Authorization (EUA) in November 2020 by the U.S. Food and agent Administration (FDA). However, Bamlanivimab is withdrawn in April 2021 following the rise of SARS-CoV-2 virus variants resistant to Bamlanivimab[1].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Benschop RJ, et al. The anti-SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccination. Sci Transl Med. 2022 Jul 27;14(655):eabn3041.

CAS Number: 2423943-37-5

Molecular Weight: N/A

Compound Purity: 99.97

Research Area: Infection

Solubility: 10 mM in DMSO

Target: SARS-CoV

• Artikelnummer: MEXHY-P99344-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99344-5
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK